Tempus ECG-AF vs iNtuition-Structural Heart Module
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at an elevated risk of developing new-onset atrial fibrillation within the next year, even without current symptoms. This tool is ideal for integrating into routine geriatric or internal medicine screenings to support earlier intervention and management strategies for AF prevention.
View Tempus ECG-AF →Choose iNtuition-Structural Heart Module if…
Choose iNtuition-Structural Heart Module if you require comprehensive, AI-powered visualization and precise measurement capabilities for detailed pre-operative planning, sizing, and post-operative evaluation of structural heart interventions. This tool is best suited for cardiologists and cardiothoracic surgeons needing advanced anatomical insights for complex procedures like TAVR, TMVR, or LAA closure.
View iNtuition-Structural Heart Module →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | iNtuition-Structural Heart Module |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Cloud-based SaaS platform. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iNtuition-Structural Heart ModuleTool B offers highly flexible deployment options, including stand-alone, server, thin client, web viewer, and SaaS, catering to diverse healthcare IT infrastructures. This broad accessibility and choice of deployment models generally lead to better usability and easier integration into various clinical workflows compared to Tool A's integrated software solution.
Clinical Value
Tempus ECG-AFTool A provides significant clinical value by using AI on standard 12-lead ECGs to identify patients at increased risk of developing Atrial Fibrillation within 12 months, enabling earlier identification and follow-up for a broad population. This predictive capability for a common and serious condition offers a substantial impact on preventative care and early disease management.
Pricing & Value
Tempus ECG-AFTool A has a clear and established CMS reimbursement pathway (CPT 0764T and CPT 0765T with a Medicare rate of $128.90), which significantly enhances its financial viability and value proposition for healthcare providers. While Tool B offers transparent subscription pricing and flexible payment options, it lacks the specific, documented reimbursement advantage of Tool A.
Enterprise Readiness
iNtuition-Structural Heart ModuleBoth tools demonstrate strong enterprise readiness with HIPAA compliance, BAA, and FDA clearance. However, Tool B's extensive deployment flexibility, including stand-alone, server, thin client, web viewer, and SaaS options, provides greater adaptability for integration into various enterprise IT environments and user preferences.
Innovation
Tempus ECG-AFTool A demonstrates a high degree of innovation by leveraging AI to predict the future risk of Atrial Fibrillation from a widely available and routine diagnostic test like a 12-lead ECG. This application of predictive AI for early risk stratification in population health represents a novel approach to proactive cardiac care.
Support & Docs
TieBoth Tempus AI and TeraRecon (now ConcertAI) are established companies that generally offer customer and technical support for their products. However, the provided structured facts and available web searches do not offer specific comparative details regarding the quality, scope, or documentation for these particular modules, making it difficult to distinguish a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | iNtuition-Structural Heart Module |
|---|---|---|
| Product Name | Tempus ECG-AF | iNtuition-Structural Heart Module |
| Company | Tempus AI, Inc. | TeraRecon |
| Primary Purpose | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | AI-powered software for cardiologists and radiologists, offering advanced visualization and precise measurements for structural heart pre-operative planning, sizing, and post-operative evaluation. |
| Target Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Cardiothoracic Surgery, Radiology |
| Key AI Application/Features | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. | Automatic and manual centerline detection; Segmentation of cardiovascular structures; Measurement tools (diameters, lengths, areas, volumes, angles); Calcium quantification and scoring; 2D/3D/4D visualization; Left Atrial Appendage (LAA) workflow; Transcatheter Mitral Valve Repair (TMVR) workflow. |
| Target Patient Group/Use Case | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, for earlier identification and follow-up of AF risk. | Structural heart pre-operative planning, sizing, and post-operative evaluation. |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and iNtuition-Structural Heart Module.